Published in Cancer Res on July 01, 1976
Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma. BMC Biotechnol (2011) 0.85
NANOSCALE SELF-ASSEMBLY FOR DELIVERY OF THERAPEUTICS AND IMAGING AGENTS. Technol Innov (2011) 0.78
Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int (1985) 4.76
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology (1974) 1.92
Correlation of bacteria lipid composition with antibiotic resistance. J Bacteriol (1970) 1.82
Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr (1979) 1.67
Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab (1973) 1.66
Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65
Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanes. Toxicol Appl Pharmacol (1998) 1.59
Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis (2007) 1.48
Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice. Carcinogenesis (2001) 1.44
Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein. Toxicol Sci (2001) 1.39
Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics (1965) 1.39
Clinical trials with exogenous interferon: summary of a meeting. J Infect Dis (1979) 1.36
Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36
HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab (1974) 1.33
Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab (1967) 1.26
Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab (1970) 1.11
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. J Nucl Med (1985) 1.08
Screening for bone metastases. Are only scans necessary? JAMA (1975) 1.06
Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab (1971) 1.06
Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res (1975) 1.05
Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology (1976) 1.04
A new cytochrome P450 from Drosophila melanogaster, CYP4G15, expressed in the nervous system. Biochem Biophys Res Commun (2000) 1.02
Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med (1972) 1.02
Allogeneic cytolysis of reconstituted membrane vesicles. Proc Natl Acad Sci U S A (1979) 0.98
Radioisotopic angiocardiography: findings in congenital heart disease. J Nucl Med (1972) 0.98
Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab (1971) 0.97
Hormone action at the membrane level. 3. Epinephrine interaction with the rat liver plasma membrane. Biochim Biophys Acta (1971) 0.95
Interpolative background subtraction. J Nucl Med (1976) 0.94
Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study. Proc Natl Acad Sci U S A (1974) 0.93
Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent. Carcinogenesis (2001) 0.91
In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med (1975) 0.91
The influence of lipid substitution on thyrotropin-receptor interactions in artificial vesicles. Endocrinology (1977) 0.91
Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab (1986) 0.91
Radioisotopic angiocardiography. Wide scope of applicability in diagnosis and evaluation of therapy in diseases of the heart and great vessels. Circulation (1971) 0.91
Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab (1973) 0.90
Hematologic toxicity of AZT and ddC administered as single agents and in combination to rats and mice. Fundam Appl Toxicol (1991) 0.89
Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies. J Clin Endocrinol Metab (1970) 0.89
HL-A antigens in Japanese Patients with Graves' disease. Tissue Antigens (1975) 0.89
Unruptured aneurysm of the sinus of valsalva producing right ventricular outflow obstruction. Am J Med (1972) 0.88
Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci (1983) 0.88
Computed tomography in Graves' ophthalmopathy. Radiology (1976) 0.88
Biochemical responses of rat and mouse lung to inhaled nickel compounds. Toxicology (1989) 0.88
Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88
Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A (1979) 0.87
Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys (1980) 0.87
From the National Institute of Allergy and Infectious Diseases. Update on clinical trials with exogenous interferon. J Infect Dis (1980) 0.86
Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J Clin Endocrinol Metab (1968) 0.85
Interferon, an antiviral drug for use in man. Tex Rep Biol Med (1977) 0.85
Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum. J Clin Endocrinol Metab (1977) 0.85
Sounding board: On white coats and other matters. N Engl J Med (1975) 0.85
Kidney and urinary bladder lesions in F344/N rats and B6C3F1 mice after 13 weeks of 2,2-bis(bromomethyl)-1,3-propanediol administration. Fundam Appl Toxicol (1989) 0.84
The long-acting thyroid stimulator and thyroid disease. Adv Intern Med (1970) 0.84
Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab (1979) 0.83
Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. Toxicol Appl Pharmacol (2003) 0.83
Bromodichloromethane, a trihalomethane that produces neoplasms in rodents. Cancer Res (1987) 0.83
The diagnosis of intracardiac metastasis of colon carcinoma by radioisotopic and roentgenographic studies. Am J Cardiol (1970) 0.83
Comparative inhalation toxicity of nickel subsulfide to F344/N rats and B6C3F1 mice exposed for 12 days. Fundam Appl Toxicol (1987) 0.83
Helper and suppressor activities of lymphocyte subsets on antithyroglobulin production in vitro. J Clin Endocrinol Metab (1985) 0.82
Tc99m labelled toluidine blue O for liver scintillography. Int J Appl Radiat Isot (1968) 0.81
Carcinogenesis bioassay of allyl isothiocyanate. Fundam Appl Toxicol (1983) 0.81
Purification of human anti-thyroglobulin. J Clin Endocrinol Metab (1975) 0.81
Combined superior vena cava obstruction and pericardial effusion demonstrated by radioisotopic angiocardiography. J Nucl Med (1970) 0.80
Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys (1985) 0.80
Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: proposed guidelines for improving data collection, distribution, and integration. Hum Mutat (2009) 0.79
Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases. J Clin Endocrinol Metab (1982) 0.79
Measurement of micronucleated erythrocytes and DNA damage during chronic ingestion of phenolphthalein in transgenic female mice heterozygous for the p53 gene. Environ Mol Mutagen (1998) 0.79
Radioisotopic angiocardiography. Preoperative and postoperative evaluation of patients with diseases of the heart and aorta. Radiol Clin North Am (1971) 0.79
Peripheral blood lymphocytes from normal individuals can be induced to secrete immunoglobulin G antibodies against self-antigen thyroglobulin in vitro. J Clin Endocrinol Metab (1985) 0.79
Developmental toxicity of orally administered 2',3'-dideoxycytidine in mice. Teratology (1990) 0.79
Toxicity of 8-methoxypsoralen, 5-methoxypsoralen, 3-carbethoxypsoralen, or 5-methylisopsoralen with ultraviolet radiation in the hairless (HRA/Skh) mouse. Toxicol Appl Pharmacol (1987) 0.79
In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids. J Clin Invest (1968) 0.79
A solid phase, sandwich-type radioimmunoassay for antithyroglobulin: elimination of false positive results and semiquantitative measurement of antithyroglobulin in the presence of elevated thyroglobulin. J Clin Endocrinol Metab (1979) 0.78
The immunotoxicity of three nickel compounds following 13-week inhalation exposure in the mouse. Fundam Appl Toxicol (1990) 0.78
Distribution and scintiphotography of a new complex, pentavalent technetium-99m citrate: studies in the rodent. J Nucl Med (1967) 0.78
Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies. J Nucl Med (1975) 0.78
Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide. J Clin Endocrinol Metab (1967) 0.77
Reproductive toxicology of methyldopa in male F344/N rats. Toxicology (1986) 0.77
Summary of the National Toxicology Program benzidine dye initiative. Environ Health Perspect (1994) 0.77
New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease. Scott Med J (1974) 0.77
Chemicals associated with decreases in the incidence of mononuclear cell leukemia in the Fischer rat. Toxicol Pathol (1997) 0.77
Toxicity and carcinogenicity of chlorodibromomethane in Fischer 344/N rats and B6C3F1 mice. Fundam Appl Toxicol (1985) 0.77
Molecular cloning of a novel crustacean member of the aldoketoreductase superfamily, differentially expressed in the antennal glands. Biochem Biophys Res Commun (2001) 0.76
Effect of detergents and sodium fluoride on the enzyme activities of the rat liver plasma membrane. Biochim Biophys Acta (1972) 0.76
Comparative inhalation toxicity of nickel sulfate to F344/N rats and B6C3F1 mice exposed for twelve days. Fundam Appl Toxicol (1988) 0.76
The long-acting thyroid stimulator. Calif Med (1968) 0.76
Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphoma. Cancer (1976) 0.76
Treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J (1979) 0.75
Simple evaluation of thyroid function. West J Med (1988) 0.75
Toxicokinetics of bis(2-chloroethoxy)methane following intravenous administration and dermal application in male and female F344/N rats and B6C3F1 mice. Toxicol Lett (2011) 0.75
Editorial: Hyperthyroidism. Calif Med (1970) 0.75
Codeine toxicokinetics in rats during a two-year dosed feed study. Drug Metab Dispos (1994) 0.75
Robert Reid Newell, 1892-1965. J Nucl Med (1966) 0.75
Guidelines and criteria for a committee authorizing the use of radioactive isotopes in humans. J Nucl Med (1967) 0.75
Degradation of C14-labeled thymidine and its halogenated analogues in man. Adv Tracer Methodol (1966) 0.75